[1] DU Xue YANG Di LI Zhongnan,.Analysis of LI Zhongnan’s Experience in Treating Melasma [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2022, (06): 45-48. [doi: 10.13424/j.cnki.jsctcm.2022.06.008]
Analysis of LI Zhongnan’s Experience in Treating Melasma
- Article number:
- 2096-1340(2022)06-0045-04
- Keywords:
- Melasma; Syndrome differentiation; Treatment experience; LI Zhongnan
- ZTFLH:
- R758.4+2
- Code:
- A
- Abstract:
- Professor LI Zhongnan is good at treating endocrine diseases with traditional Chinese medicine，and has rich clinical experience in the diagnosis and treatment of female melasma.He believes that the disease has external and internal factors，internal factors are closely related to liver，spleen and kidney dysfunction，external factors are related to natural environment and life factors.This article mainly explores the etiology and pathogenesis of melasma from the aspect of internal causes，and the mechanism of traditional Chinese medicine regulating the five internal organs.The disease is clinically divided into liver Qi stagnation type，Qi stagnation and blood stasis type，spleen Qi deficiency type，liver kidney deficiency type.The treatment mainly focuses on soothing the liver and promoting Qi，activating blood and strengthening spleen，and nourishing the liver and kidney.
References:
［1］叶世龙.黄褐斑病因病机研究［J］.中华中医药杂志,2014,29(12):3806-3808.
［2］宋晓蕾,沈芳,谢韶琼.穴位注射治疗黄褐斑研究概况［J］.中华中医药学刊,2018,36(8):1975-1978.
［3］张理平.黄褐斑病因学研究进展［J］.福建中医学院学报,2001,11(2):61-62.
［4］李艳锋,李苗苗.血府逐瘀汤辅以外用药物治疗黄褐斑并月经不调患者的疗效评价［J］.实用临床医药杂志,2020,24(9)：87-89.
［5］刘丽,赵琴.归脾汤化裁经验方对脾虚型黄褐斑患者VEGF、SOD、MDA水平的影响［J］.成都中医药大学学报，2016,39(4):55-58，62.
［6］张德华,钱方,杨玉峰,等.柴胡桂枝龙骨牡蛎汤治疗肝郁气滞型黄褐斑的临床观察［J］.广州中医药大学学报,2021,38(1)：41-45.
［7］焦海燕,严志祎,姜幼明,等.慢性束缚应激抑郁症大鼠模型的复制及逍遥散对海马色氨酸代谢途径的调节作用［J］.环球中医药,2017,10(11):1298-1302.
［8］刘继军,杨晓娟,范瑞芳.自拟疏肝健脾养颜方加减联合激光祛斑治疗黄褐斑的疗效观察［J］.中国医疗美容,2020,10(5):46-49.
［9］冯蕙裳,蔡玲玲,杨柳,等.浅析黄褐斑的辨证分型治疗［J］.环球中医药,2015,8(7):830-832.
［10］袁菊丽.白附子提取工艺的研究［J］.辽宁中医杂志，2009,36(8):1374-1375.
［11］田代华.实用中药辞典［Z］.北京:人民卫生出版社,2002:524-1288.
［12］神芳丽,赵萍萍,霍仕霞.黑素合成及相关细胞的研究进展［J］.中国医药导报,2013,10(32):33-35，38.
［13］张超伟,张钰,苏珊,等.茯苓类药材本草学、化学成分和药理作用研究进展［J］.湖北农业科学,2021,60(2):9-14,19.
［14］张明发,沈雅琴.白鲜皮药理作用的研究进展［J］.抗感染药学,2012，9(2):95-99.
［15］米红霞,刘吉平.白僵蚕应用研究进展［J］.广东蚕业,2010,44(1):46-48.
［16］涂彩霞,刘之力,任凤,等.47 种中药对酪氨酸酶活性的影响及酶动力学的研究［J］.中国麻风皮肤病杂志,2006,22(6):456-458.
［17］孙宁远,朱雪林,陈君.丹参化学成分抗纤维化药理作用及机制研究进展［J］.中国实验方剂学杂志，2020,26(22):201-208.
［18］彭宅彪,张琼光,代虹健，等.丁香酚的药理学研究进展［J］.时珍国医国药,2006,17(10)：2079-2081.
［19］郭岱炯,孙佳瑜,陈宝清,等.丹白涂膜剂对黄褐斑大鼠模型抗氧化作用及 SCF/C-kit蛋白表达的影响［J］.天津中医药,2017,34(10):699-702.
［20］梁伟,李怀军,阎新佳,等.七白颗粒对女性黄褐斑气滞血瘀证患者抗氧化作用及性激素水平的影响［J］.中国实验方剂学杂志,2017,23(20):163-168.
［21］秦静,白姗姗,边风华,等.黄褐斑中医分型与性激素水平相关性及中药疗效观察［J］.中国中西医结合皮肤性病学杂志,2013,12(5):292-294.
［22］许荣生.桃红四物汤加味治疗黄褐斑的临床疗效及抗氧化作用机制研究［J］.中医药信息,2015,32(4):100-102.
Memo
安徽省卫生健康委员会（中发展［2020］10号）；安徽中医药大学第一附属医院李中南名医工作室